Search filters

List of works by Janine Kimpel

Comparison of Four SARS-CoV-2 Neutralization Assays

scientific article published on 28 December 2020

Comparison of three humanized mouse models for adoptive T cell transfer

scientific article published on 01 August 2012

Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors

scientific article published on 31 July 2015

Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses

scientific article published on 18 December 2019

Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector

article

Lens epithelium-derived growth factor/p75 qualifies as a target for HIV gene therapy in the NSG mouse model.

scientific article published on 14 February 2012

Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer.

scientific article published on 26 April 2018

Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment

scientific article published on 29 April 2019

RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization

scientific article published on 03 July 2019

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

scientific article published on 28 November 2018

Successful return to professional men's football (soccer) competition after the COVID-19 shutdown: a cohort study in the German Bundesliga

scientific article published on 24 September 2020

Superior Therapeutic Index in Lymphoma Therapy: CD30(+) CD34(+) Hematopoietic Stem Cells Resist a Chimeric Antigen Receptor T-cell Attack.

scientific article

The Methyltransferase Region of Vesicular Stomatitis Virus L Polymerase Is a Target Site for Functional Intramolecular Insertion

scientific article published on 26 October 2019

The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.

scientific article published on 2 March 2018

The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer

scientific article published on 18 September 2019

VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.

scientific article published on 19 February 2014

Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV

scientific article published on 19 September 2019

Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum

scientific article published on 28 August 2019